SCHEMBL6010209

SCHEMBL6010209

NCCCCCCCCCOCCCN

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 6/20 0.53
CA12 O43570 2/20 0.53
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA3 P07451 2/20 0.53
CA4 P22748 2/20 0.53
CA6 P23280 2/20 0.53
CA5A P35218 2/20 0.53
CA7 P43166 2/20 0.53
CA9 Q16790 2/20 0.53
CA14 Q9ULX7 2/20 0.53
CA5B Q9Y2D0 2/20 0.53
TSHR P16473 2/20 0.53
LMNA P02545 1/20 0.53
BLM P54132 1/20 0.53
ODC1 P11926 1/20 0.47
NFKB1 P19838 1/20 0.47
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11284295 1.00 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL9745154 1.00 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL7111736 1.00 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL8658323 1.00 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL7112669 1.00 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL9746744 1.00 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL1733699 1.00 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL12444628 0.97 DNM1 (0.50) DNM1CA12CA1CA2CA3
SCHEMBL1504487 0.97 DNM1 (0.50) DNM1CA12CA1CA2CA3
SCHEMBL7745537 0.97 DNM1 (0.50) DNM1CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102007140-A Biologically active peptides BAXTER INT 2011-04-06 CN claimed
EP-0925320-A1 COATING COMPOSITIONS POLYMERISABLE AND/OR CROSS-LINKABLE BY ULTRAVIOLET OR VISIBLE LIGHT CRAY VALLEY SA (FR) 1999-06-30 EP claimed
WO-1998011152-A1 COATING COMPOSITIONS POLYMERISABLE AND/OR CROSS-LINKABLE BY ULTRAVIOLET OR VISIBLE LIGHT CRAY VALLEY S.A. (FR) 1998-03-19 WO claimed
WO-2024040169-A2 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS THE UNIVERSITY OF CHICAGO (US) 2024-02-22 WO disclosed
CN-105339411-B The epoxy-based composition of filler as honeycomb cell 3M创新有限公司 2019-04-23 CN disclosed
EP-3390552-A1 CATALYST HAVING A POLYSILOXANE STRUCTURAL UNIT FOR HARDENABLE COMPOSITIONS Sika Technology AG (CH) 2018-10-24 EP disclosed
CN-105026538-B Aqueous formulations, their preparation and their use in the cleaning of hard surfaces 巴斯夫欧洲公司 2018-03-20 CN disclosed
CN-103588958-B Mixtures of amines having guanidine derivatives 巴斯夫欧洲公司 2017-01-18 CN disclosed
CN-105392754-A Combination of ternary binder and waterborne epoxy resin system SIKA TECH AG 2016-03-09 CN disclosed
CN-105121492-A Structural polyurethane adhesive SIKA TECHNOLOGY AG 2015-12-02 CN disclosed
CN-105102602-A Formulations, their use as or for producing dishwashing detergents and their production BASF SE 2015-11-25 CN disclosed
CN-1413247-A Laundry detergent compositions comprising zwitterionic polyamines and mid-chain branched surfactants PROCTER & GAMBLE (US) 2003-04-23 CN disclosed
EP-1289563-A2 BIOTIN DERIVATIVES Mitra Medical Technology AB (SE) 2003-03-12 EP disclosed
WO-2001095857-A2 REUSABLE EXTRACORPOREAL COLUMS LOADED WITH LIGAND-DIBIOTIN CONJUGATES MITRA MEDICAL TECHNOLOGY AB (SE) 2001-12-20 WO disclosed
CN-1295558-A Novel local anesthetic compounds and uses ADVANCED MEDICINE INC (US) 2001-05-16 CN disclosed
EP-0999856-A2 RADIOPHARMACEUTICALS FOR IMAGING INFECTION AND INFLAMMATION Du Pont Pharmaceuticals Company (US) 2000-05-17 EP disclosed
WO-1999055712-A1 GROUP II MOCVD SOURCE REAGENTS, AND METHOD OF FORMING GROUP II METAL-CONTAINING FILMS UTILIZING SAME ADVANCED TECHNOLOGY MATERIALS, INC. (US) 1999-11-04 WO disclosed
EP-0925321-A1 PREPOLYMERS CONTAINING MALEIMID FUNCTIONS, METHOD OF PRODUCING AND USE THEREOF CRAY VALLEY SA (FR) 1999-06-30 EP disclosed
WO-1998015295-A2 RADIOPHARMACEUTICALS FOR IMAGING INFECTION AND INFLAMMATION DUPONT PHARMACEUTICALS COMPANY (US) 1998-04-16 WO disclosed
WO-1998011151-A1 PREPOLYMERS CONTAINING MALEIMID FUNCTIONS, METHOD OF PRODUCING AND USE THEREOF CRAY VALLEY S.A. (FR) 1998-03-19 WO disclosed